PRESS & NEWS

Caring4Caregivers Study: Enrollment Deadline October 9, 2019

caring4caregivers

Enrollment for this study has closed.

Enrollment for this study has closed.

You, or a family member, may fit the general eligibility criteria for the research study listed below. Please note:

  • This information is provided to make you aware of the study, and help direct you to where to find more information.
  • This email is not a specific endorsement of whether you should or should not consider participating in the study.
  • With any research study, you should carefully read the study description, contact the study coordinator for more information, and talk through any issues with your family and clinician(s) as appropriate.
  • This study is enrolling persons diagnosed with PSP, CBD, or FTD due to MAPT (tau) gene mutations. Biological family members of MAPT carriers are also eligible.

Researchers are inviting unpaid dementia caregivers to participate in a month-long study to evaluate a new mobile program to support caregiver well-being.

Eligible caregivers must spend at least eight hours per week caring for a family member or friend with dementia.

The study is completely offered online and requires the participant to be fluent/literate in English and own a phone that can receive text messages.

Caregivers will be asked to complete a few online questionnaires, be given access to web-based activities, and receive daily text messages for the duration of the study.

Enrollment is open until October 9, 2019, and caregivers will be compensated for their participation.

To see if you qualify, go to prochange.com/caring4caregivers. If you have questions, email Deborah at caregiver@prochange.com.

FIND ANOTHER STUDY

Together we can find a cure for ftd

The FTD Disorders Registry is a powerful tool in the movement to create therapies and find a cure. Together we can help change the course of the disease and put an end to FTD.

Your privacy is important! We promise to protect it. We will not share your contact information.

Read Full Privacy Statement

< Back to Home